Immune Thrombocytopenic Purpura (ITP)
Mairéad Ní Chonghaile, RGN, BNS, MSc, speaks on the need for training and support networks in this area of care.
Efgartigimod, a first-in-class IgG1 Fc fragment, promisingly separated from placebo in patients with chronic ITP.
The group continues their analysis of emergencies by exploring immune thrombocytopenic purpura.
The relationship between T-cell large granular lymphocytes (T-LGL) and immune thrombocytopenia (ITP) is unclear, ...
A recent publication from Fathima Haseefa and colleagues suggested that immune thrombocytopenia (ITP) was independently ...
In a recent study, researchers sought to evaluate clinical presentations, course, management, and outcomes of idiopathic ...
Researchers, led by Judit Demeter, evaluated the safety and efficacy profiles of a novel 10% human intravenous ...
In a recent meta-analysis, investigators evaluated the safety and efficacy profiles of romiplostim, a thrombopoietin ...
Advertisement
Expert Interviews on Hematology
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.